Trial intelligence / Profile preview

Tranexamic acid for blood transfusion reduction in femoral shaft fracture fixation

TCTR20220701003Phase 3Recruiting

Sponsor
Khon Kaen Hospital
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tranexamic acid in Femoral diaphyseal fracture, sponsored by Khon Kaen Hospital. Started Nov 2020; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

Femoral diaphyseal fracture

Beyond the preview

Go deeper on TCTR20220701003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220701003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call